These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26496497)

  • 1. Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response.
    Santiago FW; Halsey ES; Siles C; Vilcarromero S; Guevara C; Silvas JA; Ramal C; Ampuero JS; Aguilar PV
    PLoS Negl Trop Dis; 2015; 9(10):e0004104. PubMed ID: 26496497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
    Bopp NE; Jencks KJ; Siles C; Guevara C; Vilcarromero S; Fernández D; Halsey ES; Ampuero JS; Aguilar PV
    Am J Trop Med Hyg; 2021 Nov; 106(2):607-609. PubMed ID: 34844213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque.
    Hamilton MM; Webb EM; Peterson MC; Patel G; Porto M; Orekov T; Erasmus JH; Finneyfrock B; Cook A; Auguste AJ; Kar S
    J Gen Virol; 2024 Jul; 105(7):. PubMed ID: 38995674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mayaro Virus Infects Human Brain Cells and Induces a Potent Antiviral Response in Human Astrocytes.
    Bengue M; Ferraris P; Barthelemy J; Diagne CT; Hamel R; Liégeois F; Nougairède A; de Lamballerie X; Simonin Y; Pompon J; Salinas S; Missé D
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease.
    Mota MTO; Costa VV; Sugimoto MA; Guimarães GF; Queiroz-Junior CM; Moreira TP; de Sousa CD; Santos FM; Queiroz VF; Passos I; Hubner J; Souza DG; Weaver SC; Teixeira MM; Nogueira ML
    Sci Rep; 2020 Mar; 10(1):5306. PubMed ID: 32210270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
    Powers JM; Haese NN; Denton M; Ando T; Kreklywich C; Bonin K; Streblow CE; Kreklywich N; Smith P; Broeckel R; DeFilippis V; Morrison TE; Heise MT; Streblow DN
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009308. PubMed ID: 33793555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mayaro virus infection elicits a robust pro-inflammatory and antiviral response in human macrophages.
    Hernández-Sarmiento LJ; Tamayo-Molina YS; Valdés-López JF; Urcuqui-Inchima S
    Acta Trop; 2024 Apr; 252():107146. PubMed ID: 38342287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress.
    Camini FC; da Silva TF; da Silva Caetano CC; Almeida LT; Ferraz AC; Alves Vitoreti VM; de Mello Silva B; de Queiroz Silva S; de Magalhães JC; de Brito Magalhães CL
    Antiviral Res; 2018 Oct; 158():8-12. PubMed ID: 30076863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An emerging public health threat: Mayaro virus increases its distribution in Peru.
    Aguilar-Luis MA; Del Valle-Mendoza J; Silva-Caso W; Gil-Ramirez T; Levy-Blitchtein S; Bazán-Mayra J; Zavaleta-Gavidia V; Cornejo-Pacherres D; Palomares-Reyes C; Del Valle LJ
    Int J Infect Dis; 2020 Mar; 92():253-258. PubMed ID: 31978575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mayaro virus pathogenesis and immunity in rhesus macaques.
    Weber WC; Labriola CS; Kreklywich CN; Ray K; Haese NN; Andoh TF; Denton M; Medica S; Streblow MM; Smith PP; Mizuno N; Frias N; Fisher MB; Barber-Axthelm AM; Chun K; Uttke S; Whitcomb D; DeFilippis V; Rakshe S; Fei SS; Axthelm MK; Smedley JV; Streblow DN
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011742. PubMed ID: 37983245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
    Kantor AM; Lin J; Wang A; Thompson DC; Franz AWE
    J Med Entomol; 2019 Apr; 56(3):832-843. PubMed ID: 30668762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus.
    de Castro-Jorge LA; de Carvalho RVH; Klein TM; Hiroki CH; Lopes AH; Guimarães RM; Fumagalli MJ; Floriano VG; Agostinho MR; Slhessarenko RD; Ramalho FS; Cunha TM; Cunha FQ; da Fonseca BAL; Zamboni DS
    PLoS Pathog; 2019 Sep; 15(9):e1007934. PubMed ID: 31479495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
    Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
    mSphere; 2018; 3(2):. PubMed ID: 29577083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection.
    Kam YW; Simarmata D; Chow A; Her Z; Teng TS; Ong EK; Rénia L; Leo YS; Ng LF
    J Infect Dis; 2012 Apr; 205(7):1147-54. PubMed ID: 22389226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoarticular manifestations of Mayaro virus infection.
    Arenívar C; Rodríguez Y; Rodríguez-Morales AJ; Anaya JM
    Curr Opin Rheumatol; 2019 Sep; 31(5):512-516. PubMed ID: 31361271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
    Chow A; Her Z; Ong EK; Chen JM; Dimatatac F; Kwek DJ; Barkham T; Yang H; Rénia L; Leo YS; Ng LF
    J Infect Dis; 2011 Jan; 203(2):149-57. PubMed ID: 21288813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection.
    Ferraz AC; Almeida LT; da Silva Caetano CC; da Silva Menegatto MB; Souza Lima RL; de Senna JPN; de Oliveira Cardoso JM; Perucci LO; Talvani A; Geraldo de Lima W; de Mello Silva B; Barbosa Reis A; de Magalhães JC; Lopes de Brito Magalhães C
    Antiviral Res; 2021 Oct; 194():105168. PubMed ID: 34437912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.